Cargando…
DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer
BACKGROUND: Overcoming therapeutic resistance is one of the major hurdles in cancer care. One mechanism contributing to therapeutic resistance is a process in which epithelial cells switch to a mesenchymal state (epithelial-to-mesenchymal transition or EMT). The precise mechanisms driving EMT-mediat...
Autores principales: | Galle, Eva, Thienpont, Bernard, Cappuyns, Sarah, Venken, Tom, Busschaert, Pieter, Van Haele, Matthias, Van Cutsem, Eric, Roskams, Tania, van Pelt, Jos, Verslype, Chris, Dekervel, Jeroen, Lambrechts, Diether |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023776/ https://www.ncbi.nlm.nih.gov/pubmed/32059745 http://dx.doi.org/10.1186/s13148-020-0821-z |
Ejemplares similares
-
Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response
por: Dekervel, Jeroen, et al.
Publicado: (2016) -
Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer
por: Bulle, Ashenafi, et al.
Publicado: (2020) -
Anti-Cancer Activity of Acriflavine as Metabolic Inhibitor of OXPHOS in Pancreas Cancer Xenografts
por: Bulle, Ashenafi, et al.
Publicado: (2020) -
Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular Carcinoma
por: Brackenier, Cedric, et al.
Publicado: (2023) -
PD-1(-) CD45RA(+) effector-memory CD8 T cells and CXCL10(+) macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma
por: Cappuyns, Sarah, et al.
Publicado: (2023)